153 related articles for article (PubMed ID: 38358144)
1. Interleukin-6 and interleukin-8 levels in children with aplastic anemia and its correlation with disease severity and response to immunosuppressive therapy.
Singh A; Bhargawa SK; Yadav G; Kushwaha R; Verma SP; Tripathi T; Singh US; Tripathi AK
Ann Afr Med; 2023; 22(4):446-450. PubMed ID: 38358144
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and Interleukin-8 Levels Correlate With the Severity of Aplastic Anemia in Children.
Gupta V; Kumar S; Sonowal R; Singh SK
J Pediatr Hematol Oncol; 2017 Apr; 39(3):214-216. PubMed ID: 28060106
[TBL] [Abstract][Full Text] [Related]
3. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
4. Elevated Serum Interleukin-6 Predicts Favorable Response to Immunosuppressive Therapy in Children With Aplastic Anemia.
Lu S; Qiao X; Xie X
J Pediatr Hematol Oncol; 2017 Nov; 39(8):614-617. PubMed ID: 29068868
[TBL] [Abstract][Full Text] [Related]
5. Post-therapeutic recovery of serum interleukin-35 level might predict positive response to immunosuppressive therapy in pediatric aplastic anemia.
Huang Z; Tong H; Li Y; Zhou H; Qian J; Wang J; Ruan J
Hematology; 2017 Aug; 22(7):430-436. PubMed ID: 28211781
[TBL] [Abstract][Full Text] [Related]
6. [Role of Th17/Treg imbalance in the immune pathogenesis and treatment of children with aplastic anemia].
Liu K; Wang H; Xie Z; Chu J; Wang Y; Dai Y; Yang L; Tan J; Wang N
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):927-31. PubMed ID: 25619351
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
Jalaeikhoo H; Khajeh-Mehrizi A
PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
[TBL] [Abstract][Full Text] [Related]
8. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
[TBL] [Abstract][Full Text] [Related]
9. Response To Immunosuppressive Therapy In Patients Of Acquired Aplastic Anaemia: A Single Center Experience From A Developing Country.
Khan M; Iftikhar R; Chaudhry QU; Mehmood SK; Faraz T; Ghafoor T; Shahbaz N; Khan MA; Shamshad GU; Khattak TA
J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S969-S973. PubMed ID: 36550655
[TBL] [Abstract][Full Text] [Related]
10. [The Efficacy and Influencing Factors of Cyclosporine Alone in the Treatment of Children with Acquired Aplastic Anemia].
Qin HC; Guan XM; Hu YN; Lei XY; Dou Y; Yu J; Wen XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):841-846. PubMed ID: 38926977
[TBL] [Abstract][Full Text] [Related]
11. [The relationship of telomere and telomerase activity with outcome of aplastic anemia after immunosuppressive therapy].
Song JY; Kuang LP; Wang Y; Li YH; Wu JL; Zhang H; Li L; Wang YC; Jiang ZJ; Xiao Y
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):771-6. PubMed ID: 24103875
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of bone marrow and blood plasma levels of IL-2 in aplastic anaemia and their relationship with disease severity.
De R; Dutta A; Dolai TK; Ghosh K; Halder A
Hematology; 2019 Dec; 24(1):84-88. PubMed ID: 30139310
[TBL] [Abstract][Full Text] [Related]
13. [The impact of immunosuppressive therapy on genetic instabilities of bone marrow hematopoietic cells in patients with aplastic anemia].
Zhang LH; Wang HJ; Zhang L; Zhou K; Yang DL; Yan ZS; Li HQ; Liu QG; Qi JY; Liu Q; Chu YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):728-32. PubMed ID: 19176006
[TBL] [Abstract][Full Text] [Related]
14. [The life span of red blood cell in patients with severe/very severe aplastic anemia].
Ye L; Guo J; Jing LP; Peng GX; Zhou K; Li Y; Li Y; Li JP; Fan HH; Song L; Zhang FK; Zhang L
Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):137-142. PubMed ID: 29562449
[No Abstract] [Full Text] [Related]
15. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
[TBL] [Abstract][Full Text] [Related]
16. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
Zhang X; Li Z; Geng W; Song B; Wan C
Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children.
Yagasaki H; Shichino H; Ohara A; Kobayashi R; Yabe H; Ohga S; Hamamoto K; Ohtsuka Y; Shimada H; Inoue M; Muramatsu H; Takahashi Y; Kojima S
Ann Hematol; 2014 May; 93(5):747-52. PubMed ID: 24337487
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells in peripheral blood at diagnosis predict response to immunosuppressive therapy in severe aplastic anemia.
Yu W; Wang Q; Ge M; Shi X
Clin Exp Med; 2023 Sep; 23(5):1815-1822. PubMed ID: 36244022
[TBL] [Abstract][Full Text] [Related]
19. [Effects of concentration of cyclosporine A on the early response to immunosuppressive therapy in severe aplastic anemia].
Liang LY; Zhang L; Jing LP; Zhou K; Wang XD; Li Y; Peng GX; Li Y; Li JP; Shi LH; Ye L; Fan HH; Zhang P; Chu YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):766-71. PubMed ID: 22339914
[TBL] [Abstract][Full Text] [Related]
20. Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study.
Norasetthada L; Wongkhantee S; Chaipokam J; Charoenprasert K; Chuncharunee S; Rojnuckarin P; Sirijerachai C; Wanachiwanawin W; Issaragrisil S;
Ann Hematol; 2021 Oct; 100(10):2443-2452. PubMed ID: 34269837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
